About 20.1 million adults 20 years and older in the United States have coronary artery disease, and chest pain can be an unpleasant frequent reality for many of those people. There are many different ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

Ahmedabad: Zydus Lifesciences Limited received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Isosorbide Mononitrate Extended-Release, Tablets USP ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Zydus Lifesciences Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic Isosorbide Mononitrate extended-release tablets used to prevent ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO, Fla. — Isosorbide mononitrate did not improve activity level, exercise capacity or quality of life of ...

Zydus Lifesciences Limited’s shares went up 1.40 per cent after the company secured final approval from the United States Food and Drug Administration (USFDA) for the production and distribution of ...

Medindia updates the prices regularly, however, there may be slight discrepancies in the prices displayed. This can be due to the following reasons:Medindia updates the prices regularly, however, ...

Sublingual isosorbide dinitrate, 5 mg, combined with oral propranolol, 40 mg, was given four times daily for six weeks to 23 patients with angina pectoris. The effects were compared with those of ...